GNH USA

Europe — EMA

Levotuss (Levodropropizine)

GNH USA supplies Levotuss (Levodropropizine), a cough suppressant for acute and chronic cough, in oral form with packaging. Request a quote for global supply.

Levodropropizine

Request sourcing

1
Pack/s

What is Levodropropizine?

Levodropropizine, the active ingredient in Levotuss, is an antitussive presented as an oral formulation for oral use. It is used to relieve cough in patients with acute, chronic or infection‑related irritation of the respiratory tract. GNH USA supplies Levotuss as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

What is Levodropropizine used for?

Levodropropizine acts on the peripheral cough pathway to reduce the cough reflex. - Acute cough: provides symptomatic relief of non‑productive cough episodes. - Chronic cough: helps decrease cough frequency in persistent cough conditions. - Cough associated with upper respiratory tract infections: alleviates irritation‑driven cough.

What are the side effects of Levodropropizine?

Levodropropizine is generally well tolerated, but adverse reactions can occur.

Common Side Effects: - Nausea: mild to moderate stomach upset. - Dizziness: transient light‑headedness. - Headache: occasional mild headache. - Dry mouth: reduced salivation. - Abdominal discomfort: mild stomach pain. - Altered taste: temporary metallic or bitter taste.

Serious or Rare Side Effects: - Allergic reactions: rash, pruritus, or urticaria. - Angioedema: swelling of face, lips or tongue. - Severe hepatic injury: rare cases of liver enzyme elevation. - Anaphylaxis: life‑threatening hypersensitivity. - Blood dyscrasias: rare hematologic abnormalities.

What precautions apply to Levodropropizine?

Before initiating therapy, consider the following precautions. - Assess renal function: adjust use in severe renal impairment. - Monitor for hypersensitivity: discontinue if allergic signs appear. - Avoid in patients with known levodropropizine allergy. - Use with caution in pregnancy: limited safety data available. - Use with caution while breastfeeding: unknown excretion in milk. - Store at room temperature: keep in the original pack, protect from moisture.

What does Levodropropizine interact with?

Levodropropizine may interact with other medicines; review the following.

Major Interactions (Avoid): - Strong CYP3A4 inhibitors: may increase levodropropizine exposure. - Concurrent use with other antitussives: risk of additive cough suppression.

Moderate Interactions (Monitor Closely): - Antihistamines: possible enhanced sedative effect. - Bronchodilators: monitor for altered efficacy. - Alcohol: may increase dizziness or gastrointestinal upset.

Frequently asked questions

What is Levotuss used for?+
Levotuss contains levodropropizine, a peripheral antitussive indicated for the symptomatic relief of cough associated with acute, chronic or infection‑related irritation of the respiratory tract. It helps reduce the frequency and intensity of non‑productive cough in adults and children as prescribed by a healthcare professional.
How does levodropropizine work?+
Levodropropizine acts on sensory C‑fibers located in the airway mucosa. By inhibiting these peripheral nerve endings, it diminishes the afferent signals that trigger the cough reflex, providing relief without affecting central nervous system pathways, which distinguishes it from opioid‑based cough suppressants.
What is the usual dose of Levotuss?+
The specific dose of Levotuss is determined by the prescribing clinician based on the patient’s age, weight, severity of cough and overall health status. Healthcare providers follow local prescribing guidelines and adjust the regimen as needed; patients should follow the exact instructions given by their prescriber.
Is Levotuss safe during pregnancy or breastfeeding?+
Safety data for levodropropizine in pregnancy and lactation are limited. The product should be used only if the potential benefit justifies any possible risk to the fetus or infant. Women who are pregnant, planning to become pregnant, or breastfeeding should discuss the use of Levotuss with their healthcare provider.
How do I order Levotuss from GNH USA?+
To order Levotuss, submit an enquiry on the product page at gnh-usa.com, specifying the required quantity. GNH USA supplies hospitals, pharmacies and procurement teams worldwide, and will request verification of trade or institutional credentials. After confirmation, the team provides pricing, availability, shipping details and any necessary import documentation.
How does Levotuss compare with other cough suppressants?+
Levotuss (levodropropizine) is a non‑opioid, peripheral antitussive, whereas many alternatives such as codeine or dextromethorphan act centrally on the brainstem cough center. Levodropropizine typically has a lower risk of sedation, dependence and respiratory depression, making it suitable for patients where central agents are contraindicated.
How should Levotuss be stored and handled?+
Levotuss should be stored at room temperature, below 25 °C, in its original container to protect it from moisture and light. Keep the product out of reach of children and avoid storing it in areas with high humidity or extreme temperatures to maintain its stability and efficacy.
How is Levotuss administered?+
Levotuss is taken orally. The tablet or liquid should be swallowed (or measured and ingested) according to the prescriber’s instructions, typically with or without food. Patients should not crush or chew tablets unless specifically advised, and should use a proper measuring device for liquid forms.
What are the most serious risks associated with Levotuss?+
Serious adverse reactions, although rare, include allergic responses such as rash, urticaria, angioedema and, in extreme cases, anaphylaxis. Hepatic injury and blood dyscrasias have also been reported infrequently. Patients should seek immediate medical attention if they experience swelling of the face or throat, difficulty breathing, or signs of a severe allergic reaction.
Who should not use Levotuss?+
Levotuss is contraindicated in individuals with a known hypersensitivity to levodropropizine or any of the excipients in the formulation. It should also be avoided in patients who have experienced severe allergic reactions to other peripheral antitussives. Clinicians should assess each patient’s medical history before prescribing.
Information provided on this page is for educational use by procurement and clinical professionals. Always consult a licensed healthcare provider for medical advice and prescribing decisions. GNH USA supplies this product subject to applicable regulatory and licensing requirements.
Send a sourcing enquiry for this product →

Product details

Drug
Levodropropizine
Route
Oral Use
Manufacturer
Arriani Pharmaceuticals S.A.
Origin
EU

Related products

Adrimax

Adrimax

Levodropropizine

Zaklady Farmaceutyczne Polpharma S.A.
EU
Angituss

Angituss

Levodropropizine

Alfasigma España, S.L.
EU
Cetirol

Cetirol

Levodropropizine

Raldex Enterprises Ltd
EU
Cetirol

Cetirol

Levodropropizine

Raldex Enterprises Ltd
EU